OBJECTIVE: To compare melanoma trends within Florida with national melanoma trends from 1992 through 2004. An analysis of state and national melanoma trends is critical for the identification of high-risk regions of the country. DESIGN: Data from the Florida Cancer Data System (FCDS) and Surveillance, Epidemiology, and End Results (SEER) were evaluated to determine age-adjusted and race/ethnicity- and sex-specific invasive cutaneous melanoma incidence trends for 1992 through 2004 using joinpoint regression analysis. Standardized incidence rate ratios (SIRRs) were computed to compare Florida with the United States. PATIENTS: A population of 109 633 patients with invasive melanoma was evaluated: 73 206 (66.8%) from SEER and 36 427 (33.2%) from FCDS. MAIN OUTCOME MEASURES: Melanoma incidence and change in melanoma rates over time. RESULTS: The incidence of melanoma among male Hispanic patients residing in Florida was 20% higher than that of their male counterparts in the SEER catchment areas (SIRR, 1.2; 95% confidence interval [CI], 1.1-1.4). Conversely, the incidence of melanoma among female Hispanic patients residing in Florida was significantly lower than that in SEER (SIRR, 0.7; 95% CI, 0.7-0.8). Differences in melanoma incidence were identified in female non-Hispanic black (NHB) patients in Florida who had a 60% significantly higher incidence of melanoma compared with female NHB patients in SEER (SIRR, 1.6; 95% CI, 1.3-2.0). CONCLUSION: These findings suggest an emerging public health concern in race/ethnic subgroups that were previously understudied.
OBJECTIVE: To compare melanoma trends within Florida with national melanoma trends from 1992 through 2004. An analysis of state and national melanoma trends is critical for the identification of high-risk regions of the country. DESIGN: Data from the Florida Cancer Data System (FCDS) and Surveillance, Epidemiology, and End Results (SEER) were evaluated to determine age-adjusted and race/ethnicity- and sex-specific invasive cutaneous melanoma incidence trends for 1992 through 2004 using joinpoint regression analysis. Standardized incidence rate ratios (SIRRs) were computed to compare Florida with the United States. PATIENTS: A population of 109 633 patients with invasive melanoma was evaluated: 73 206 (66.8%) from SEER and 36 427 (33.2%) from FCDS. MAIN OUTCOME MEASURES: Melanoma incidence and change in melanoma rates over time. RESULTS: The incidence of melanoma among male Hispanic patients residing in Florida was 20% higher than that of their male counterparts in the SEER catchment areas (SIRR, 1.2; 95% confidence interval [CI], 1.1-1.4). Conversely, the incidence of melanoma among female Hispanic patients residing in Florida was significantly lower than that in SEER (SIRR, 0.7; 95% CI, 0.7-0.8). Differences in melanoma incidence were identified in female non-Hispanic black (NHB) patients in Florida who had a 60% significantly higher incidence of melanoma compared with female NHB patients in SEER (SIRR, 1.6; 95% CI, 1.3-2.0). CONCLUSION: These findings suggest an emerging public health concern in race/ethnic subgroups that were previously understudied.
Authors: Kimberly A Miller; Jimi Huh; Jennifer B Unger; Jean L Richardson; Martin W Allen; David H Peng; Myles G Cockburn Journal: Prev Med Date: 2015-10-05 Impact factor: 4.018
Authors: Kirsten A M White; Yvonne T Dailey; Dolores D Guest; Kate Zielaskowski; Erika Robers; Andrew Sussman; Keith Hunley; Christopher R Hughes; Matthew R Schwartz; Kimberly A Kaphingst; David B Buller; Jennifer L Hay; Marianne Berwick Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-09-05 Impact factor: 4.254
Authors: Jennifer L Hay; Kate Zielaskowski; Kirsten Meyer White; Kimberly Kaphingst; Erika Robers; Dolores Guest; Andrew Sussman; Yvonne Talamantes; Matthew Schwartz; Vivian M Rodríguez; Yuelin Li; Elizabeth Schofield; Jessica Bigney; Keith Hunley; David Buller; Marianne Berwick Journal: JAMA Dermatol Date: 2018-06-01 Impact factor: 10.282
Authors: John Charles A Lacson; Scarlet H Doyle; Jocelyn Del Rio; Stephanie M Forgas; Rodrigo Carvajal; Guillermo Gonzalez-Calderon; Adriana Ramírez Feliciano; Youngchul Kim; Richard G Roetzheim; Steven K Sutton; Susan T Vadaparampil; Brenda Soto-Torres; Peter A Kanetsky Journal: Cancer Res Commun Date: 2022-01-11